Company profile: BBI Solutions
1.1 - Company Overview
Company description
- Provider of raw materials and test technology platforms for the diagnostics market, offering monoclonal and polyclonal antibodies for antigen identification, custom antibody manufacturing and conjugation services, matched antibody pairs for capture and detection, and Novarum, a smartphone platform that turns a phone into a diagnostic test reader to read and share rapid test results at the point of care.
Products and services
- Antibodies: Assay-ready range of monoclonal and polyclonal antibodies engineered to identify and capture target antigens in diagnostic applications for reliable biomarker detection and test development
- Matched Antibody Pairs: Pre-matched assemblies comprising capture and detection antibodies, each recognizing different antigen epitopes, enabling precise capture–detection interactions in diagnostic assays
- Novarum: Smartphone-integrated platform that transforms a phone into a diagnostic test reader, enabling users to read and share rapid test results from the point of care
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to BBI Solutions
InVitro International
HQ: United States
Website
- Description: Provider of proprietary non-animal testing alternatives, with a pioneering focus on their development and application.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full InVitro International company profile →
Echelon Biosciences
HQ: United States
Website
- Description: Provider of tools and reagents for biomedical research and drug discovery, including Membrane Lipid Strips for protein-lipid interaction assays; PIP3 Mass ELISA for PI(3,4,5)P3 detection; lipid antibodies; Hyaluronidase Activity ELISA; neuroscience resources for nervous system studies; and cell membrane resources for lipid-protein interactions and membrane analysis.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Echelon Biosciences company profile →
Syndesi Therapeutics
HQ: Belgium
Website
- Description: Provider of drug candidates and molecules that uniquely modulate the synaptic vesicle protein SV2A to regulate synaptic transmission, representing a promising approach to treating Alzheimer’s disease and other neurological disorders with cognitive impairment.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Syndesi Therapeutics company profile →
Repligen
HQ: United States
Website
- Description: Provider of consumable bioprocessing products and systems for manufacturing biological drugs, including KrosFlo TFF systems for ultrafiltration, diafiltration and microfiltration; XCell ATF cell-retention systems, available in single-use or stainless steel formats; NGL COVID-19 spike protein affinity resin; CTech FlowVPX in-line spectrophotometry for GMP testing; ProConnex single-use flow paths; and fluid storage and transfer solutions.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Repligen company profile →
Inixium
HQ: Canada
Website
- Description: Provider of customer-centric CRO services offering critical knowledge-based expertise in structural biology to biotech and pharmaceutical industries globally throughout the early phases of drug discovery.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Inixium company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for BBI Solutions
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to BBI Solutions
2.2 - Growth funds investing in similar companies to BBI Solutions
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for BBI Solutions
4.2 - Public trading comparable groups for BBI Solutions
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →